Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799578

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799578

Global Neuroprosthetics Market Size Study & Forecast, by Type (Motor Prosthetics, Cochlear Implants, Cognitive Prosthetics, Retinal Implants), by Technology, by Application and Regional Forecasts 2025-2035

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Neuroprosthetics Market, valued at approximately USD 14.69 billion in 2024, is projected to expand at a striking CAGR of 15.60% during 2025-2035, ultimately reaching USD 72.37 billion. Neuroprosthetics, often seen as the confluence of neuroscience and advanced engineering, are transformative devices that replace or enhance the function of a damaged nervous system or sensory organ. They range from motor prosthetics restoring movement in paralyzed limbs to cochlear implants reviving hearing for the deaf. The demand curve is steeply upward, driven by rising incidences of neurological disorders, rapid advancements in brain-computer interface technologies, and increasing global investments in neuroengineering research. Aging populations, coupled with the growing acceptance of bio-integrated devices, are further steering the industry into a phase of accelerated innovation and commercialization.

The remarkable surge in adoption can be attributed to expanding clinical applications, from restoring motor function after spinal cord injuries to enhancing cognitive abilities in neurodegenerative conditions. According to the World Health Organization, neurological disorders are now the leading cause of disability-adjusted life years globally. This reality has sparked multi-billion-dollar investments in R&D by both public and private sectors, with AI-driven prosthetics and wireless neural interface systems gaining significant traction. In parallel, breakthroughs in material sciences-such as biocompatible electrodes and ultra-flexible implants-are enabling longer device lifespans and reducing patient rejection rates. However, the market still faces barriers, including high implantation costs, complex regulatory pathways, and ethical concerns around cognitive enhancement technologies, which could temper growth in certain regions.

From a regional perspective, North America commanded the lion's share of the neuroprosthetics market in 2024, owing to its advanced healthcare infrastructure, early technology adoption, and substantial funding in neuroscience research. Europe follows closely, propelled by strong medical device manufacturing capabilities and increasing demand for advanced neural rehabilitation solutions. Meanwhile, Asia Pacific is poised to witness the fastest growth, driven by a sharp rise in neurological disorder prevalence, growing healthcare expenditure in China and India, and an expanding network of specialized neurological care centers. The Middle East & Africa, though at a nascent stage, is beginning to embrace these technologies through government-backed healthcare modernization programs and partnerships with international device manufacturers.

Major market player included in this report are:

  • Medtronic plc
  • Cochlear Ltd.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Sonova Holding AG
  • NeuroPace Inc.
  • Second Sight Medical Products, Inc.
  • LivaNova PLC
  • Oticon Medical
  • Retina Implant AG
  • MicroPort Scientific Corporation
  • BioControl Medical
  • Axonics, Inc.
  • Synchron Inc.
  • Nevro Corp.

Global Neuroprosthetics Market Report Scope:

  • Historical Data - 2023, 2024
  • Base Year for Estimation - 2024
  • Forecast period - 2025-2035
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Type:

  • Motor Prosthetics
  • Cochlear Implants
  • Cognitive Prosthetics
  • Retinal Implants

By Technology:

  • (Technology segments to be inserted based on specific dataset availability)

By Application:

  • (Application segments to be inserted based on specific dataset availability)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2025 to 2035.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Neuroprosthetics Market Report Scope & Methodology

  • 1.1. Research Objective
  • 1.2. Research Methodology
    • 1.2.1. Forecast Model
    • 1.2.2. Desk Research
    • 1.2.3. Top Down and Bottom-Up Approach
  • 1.3. Research Attributes
  • 1.4. Scope of the Study
    • 1.4.1. Market Definition
    • 1.4.2. Market Segmentation
  • 1.5. Research Assumption
    • 1.5.1. Inclusion & Exclusion
    • 1.5.2. Limitations
    • 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

  • 2.1. CEO/CXO Standpoint
  • 2.2. Strategic Insights
  • 2.3. ESG Analysis
  • 2.4. key Findings

Chapter 3. Global Neuroprosthetics Market Forces Analysis

  • 3.1. Market Forces Shaping The Global Neuroprosthetics Market (2024-2035)
  • 3.2. Drivers
    • 3.2.1. Rising prevalence of neurological disorders and aging demographics
    • 3.2.2. Advancements in brain-computer interfaces, AI-enabled prosthetics, and biocompatible materials
  • 3.3. Restraints
    • 3.3.1. High implantation and lifetime maintenance costs; reimbursement variability
    • 3.3.2. Complex regulatory pathways and ethical/data-privacy concerns in cognitive enhancement
  • 3.4. Opportunities
    • 3.4.1. Rapid adoption across Asia Pacific and emerging markets with expanding specialty centers
    • 3.4.2. Shift toward minimally invasive, wireless neuromodulation and home-based care integration

Chapter 4. Global Neuroprosthetics Industry Analysis

  • 4.1. Porter's 5 Forces Model
    • 4.1.1. Bargaining Power of Buyer
    • 4.1.2. Bargaining Power of Supplier
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Forecast Model (2024-2035)
  • 4.3. PESTEL Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top Investment Opportunities
  • 4.5. Top Winning Strategies (2025)
  • 4.6. Market Share Analysis (2024-2025)
  • 4.7. Global Pricing Analysis And Trends 2025
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Neuroprosthetics Market Size & Forecasts by Type 2025-2035

  • 5.1. Market Overview
  • 5.2. Global Neuroprosthetics Market Performance - Potential Analysis (2025)
  • 5.3. Motor Prosthetics
    • 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.3.2. Market size analysis, by region, 2025-2035
  • 5.4. Cochlear Implants
    • 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.4.2. Market size analysis, by region, 2025-2035
  • 5.5. Cognitive Prosthetics
    • 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.5.2. Market size analysis, by region, 2025-2035
  • 5.6. Retinal Implants
    • 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.6.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Neuroprosthetics Market Size & Forecasts by Application 2025-2035

  • 6.1. Market Overview
  • 6.2. Global Neuroprosthetics Market Performance - Potential Analysis (2025)
  • 6.3. Motor Restoration & Mobility
    • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.3.2. Market size analysis, by region, 2025-2035
  • 6.4. Sensory Restoration (Hearing & Vision)
    • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.4.2. Market size analysis, by region, 2025-2035
  • 6.5. Neuromodulation (Epilepsy, Movement Disorders, Pain)
    • 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.5.2. Market size analysis, by region, 2025-2035
  • 6.6. Cognitive & Memory Enhancement and Others
    • 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.6.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Neuroprosthetics Market Size & Forecasts by Region 2025-2035

  • 7.1. Neuroprosthetics Market, Regional Market Snapshot
  • 7.2. Top Leading & Emerging Countries
  • 7.3. North America Neuroprosthetics Market
    • 7.3.1. U.S. Neuroprosthetics Market
      • 7.3.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.3.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.3.2. Canada Neuroprosthetics Market
      • 7.3.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.3.2.2. Application breakdown size & forecasts, 2025-2035
  • 7.4. Europe Neuroprosthetics Market
    • 7.4.1. UK Neuroprosthetics Market
      • 7.4.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.2. Germany Neuroprosthetics Market
      • 7.4.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.3. France Neuroprosthetics Market
      • 7.4.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.3.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.4. Spain Neuroprosthetics Market
      • 7.4.4.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.4.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.5. Italy Neuroprosthetics Market
      • 7.4.5.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.5.2. Application breakdown size & forecasts, 2025-2035
    • 7.4.6. Rest of Europe Neuroprosthetics Market
      • 7.4.6.1. Type breakdown size & forecasts, 2025-2035
      • 7.4.6.2. Application breakdown size & forecasts, 2025-2035
  • 7.5. Asia Pacific Neuroprosthetics Market
    • 7.5.1. China Neuroprosthetics Market
      • 7.5.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.2. India Neuroprosthetics Market
      • 7.5.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.3. Japan Neuroprosthetics Market
      • 7.5.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.3.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.4. Australia Neuroprosthetics Market
      • 7.5.4.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.4.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.5. South Korea Neuroprosthetics Market
      • 7.5.5.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.5.2. Application breakdown size & forecasts, 2025-2035
    • 7.5.6. Rest of APAC Neuroprosthetics Market
      • 7.5.6.1. Type breakdown size & forecasts, 2025-2035
      • 7.5.6.2. Application breakdown size & forecasts, 2025-2035
  • 7.6. Latin America Neuroprosthetics Market
    • 7.6.1. Brazil Neuroprosthetics Market
      • 7.6.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.6.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.6.2. Mexico Neuroprosthetics Market
      • 7.6.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.6.2.2. Application breakdown size & forecasts, 2025-2035
  • 7.7. Middle East and Africa Neuroprosthetics Market
    • 7.7.1. UAE Neuroprosthetics Market
      • 7.7.1.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.1.2. Application breakdown size & forecasts, 2025-2035
    • 7.7.2. Saudi Arabia (KSA) Neuroprosthetics Market
      • 7.7.2.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.2.2. Application breakdown size & forecasts, 2025-2035
    • 7.7.3. South Africa Neuroprosthetics Market
      • 7.7.3.1. Type breakdown size & forecasts, 2025-2035
      • 7.7.3.2. Application breakdown size & forecasts, 2025-2035

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Medtronic plc
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Financial Performance (Subject to Data Availability)
    • 8.2.5. Product/Services Port
    • 8.2.6. Recent Development
    • 8.2.7. Market Strategies
    • 8.2.8. SWOT Analysis
  • 8.3. Cochlear Ltd.
  • 8.4. Boston Scientific Corporation
  • 8.5. Abbott Laboratories
  • 8.6. Sonova Holding AG
  • 8.7. NeuroPace Inc.
  • 8.8. Second Sight Medical Products, Inc.
  • 8.9. LivaNova PLC
  • 8.10. Oticon Medical
  • 8.11. Retina Implant AG
  • 8.12. MicroPort Scientific Corporation
  • 8.13. BioControl Medical
  • 8.14. Axonics, Inc.
  • 8.15. Synchron Inc.
  • 8.16. Nevro Corp.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!